Lv1
30 积分 2023-04-25 加入
The hallmarks of cancer immune evasion
3小时前
待确认
Peptide-to-Small Molecule: A Pharmacophore-Guided Small Molecule Lead Generation Strategy from High-Affinity Macrocyclic Peptides
13天前
已完结
Progress and challenges in glypican-3 targeting for hepatocellular carcinoma therapy
24天前
已完结
Synthesis and Evaluation of (68)Ga- and (177)Lu-Labeled [Pro(14)]bombesin(8-14) Derivatives for Detection and Radioligand Therapy of Gastrin-Releasing Peptide Receptor-Expressing Cancer
25天前
已完结
Tumor Targeting Properties of Indium-111 Labeled Genetically Engineered Fab′ and F(ab′)2 Constructs of Chimeric Tumor Necrosis Treatment (chTNT)-3 Antibody
26天前
已完结
[177Lu]Lu-PSMA-617 theranostic probe for hepatocellular carcinoma imaging and therapy
27天前
已完结
Development of [177Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression
27天前
已完结
Biomarker analysis of a randomized, placebo-controlled, double-blind, multicenter phase II trial of intravenous RO5137382/GC33 at 1600 mg Q2W in previously treated patients with unresectable advanced or metastatic hepatocellular carcinoma (HCC) (NCT01507168)
27天前
已关闭
GPC3-targeted immunoPET imaging of hepatocellular carcinomas
28天前
已完结
Progress toward Barium Tagging in High Pressure Xenon Gas with Single Molecule Fluorescence Imaging
1个月前
已完结
皖公网安备34019202002308
